United States Gynecological Devices Market Outlook to 2023

GlobalData
68 Pages - GLDATA62209
$4,995.00

Summary

GlobalData’s new report, "United States Gynecological Devices Market Outlook to 2023", provides key market data on the United States Gynecological Devices market. The report provides value, in millions of US dollars, volume (in units) and and average prices (USD) within market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Gynecological Devices market segments - Female Sterilization Devices, Endometrial Ablation Devices, Uterine Fibroid Ablation Devices and Uterine Fibroid Embolization Agents.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2009 to 2016 and forecast to 2023.
- 2016 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Gynecological Devices market.
- Key players covered include Hologic Inc, CooperSurgical Inc, Bayer AG and Others.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.

Companies Mentioned

Bayer AG
Utah Medical Products, Inc.
Hologic Inc
Ethicon Inc
Merit Medical Systems, Inc.
Boston Scientific Corp
Cook Group Inc
CooperSurgical Inc

'

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Gynecological Devices Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Gynecological Devices Market, United States 9
3.1 Gynecological Devices Market, United States, Revenue ($m), 2009-2016 9
3.2 Gynecological Devices Market, United States, Revenue ($m), 2016-2023 11
3.2.1 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 13
3.2.2 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2009-2016 15
3.2.3 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2009-2016 17
3.2.4 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2009-2016 18
3.2.5 Endometrial Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 20
3.2.6 Female Sterilization Devices Market, United States, Revenue ($m), by Segment, 2016-2023 22
3.2.7 Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), by Segment, 2016-2023 24
3.2.8 Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), by Segment, 2016-2023 25
3.3 Gynecological Devices Market, United States, Volume (Units), 2009-2016 27
3.4 Gynecological Devices Market, United States, Volume (Units), 2016-2023 29
3.4.1 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 31
3.4.2 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2009-2016 33
3.4.3 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2009-2016 35
3.4.4 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2009-2016 36
3.4.5 Endometrial Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 38
3.4.6 Female Sterilization Devices Market, United States, Volume (Units), by Segment, 2016-2023 40
3.4.7 Uterine Fibroid Ablation Devices Market, United States, Volume (Units), by Segment, 2016-2023 42
3.4.8 Uterine Fibroid Embolization Agents Market, United States, Volume (Units), by Segment, 2016-2023 43
3.5 Gynecological Devices Market, United States, Average Price ($), 2009-2023 45
3.6 Gynecological Devices Market, United States, Distribution Share by Revenue ($m), 2016 47
3.7 Gynecological Devices Market, United States, Company Share by Revenue ($m), 2016 48
4 Overview of Key Companies in United States, Gynecological Devices Market 50
4.1 Bayer AG 50
4.1.1 Company Overview 50
4.2 Utah Medical Products, Inc. 50
4.2.1 Company Overview 50
4.3 Hologic Inc 50
4.3.1 Company Overview 50
4.4 Ethicon Inc 51
4.4.1 Company Overview 51
4.5 Merit Medical Systems, Inc. 51
4.5.1 Company Overview 51
4.6 Boston Scientific Corp 51
4.6.1 Company Overview 51
4.7 Cook Group Inc 51
4.7.1 Company Overview 51
4.8 CooperSurgical Inc 52
4.8.1 Company Overview 52
5 Gynecological Devices Market Pipeline Products 53
6 Financial Deals Landscape 54
6.1 Acquisition 54
6.1.1 Hologic Acquires Cynosure in Tender Offer 54
7 Recent Developments 56
7.1 Corporate Communications 56
7.1.1 Nov 15, 2016: Cynosure Health Welcomes Three New Board Members 56
7.1.2 Nov 01, 2016: Cynosure Promotes Doug Delaney to Chief Commercial Officer 56
7.1.3 Sep 13, 2016: Cynosure to Name Stephen J. Webber as New Chief Financial Officer 57
7.1.4 May 25, 2016: Cynosure Announces Planned Retirement of Timothy W. Baker as President, Chief Financial Officer and Chief Operating Officer 57
7.2 Financial Announcements 58
7.2.1 Feb 07, 2017: Cynosure Achieves Record Quarterly Revenue of $122.1 Million in the Fourth Quarter of 2016, Up 19 Percent Year-over-Year 58
7.2.2 Oct 25, 2016: Cynosure Announces Record Third-Quarter Revenues; Revenues Increase 36 Percent from Prior Year to $106.4 Million 59
7.2.3 Jul 26, 2016: Cynosure Reports Net Income of $6.3 Million on Record Sales of $110.3 Million for the Second Quarter of 2016 60
8 Appendix 62
8.1 Research Methodology 63
8.1.1 Coverage 63
8.1.2 Secondary Research 63
8.1.3 Primary Research 64
8.1.4 Market Modeling and Forecasting 65
8.1.5 Company Share Analysis 66
8.1.6 Distribution Share Analysis 67
8.1.7 Benchmarking 67
8.2 GlobalData Consulting 67
8.3 Contact Us 68
8.4 Disclaimer 68

1.1 List of Tables
Table 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 10
Table 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 12
Table 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 14
Table 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 16
Table 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
Table 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 19
Table 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 21
Table 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 23
Table 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
Table 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 26
Table 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 28
Table 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 30
Table 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 32
Table 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 34
Table 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 35
Table 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 37
Table 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 39
Table 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 41
Table 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 42
Table 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 44
Table 21: Gynecological Devices Market, United States, Average Price ($) Historic, 2009-2016 45
Table 22: Gynecological Devices Market, United States, Average Price ($), Forecast, 2016-2023 46
Table 23: Gynecological Devices Market, United States, Distribution Share by Revenue ($m), USD Constant, 2016 47
Table 24: Gynecological Devices Market, United States, Company Share by Revenue ($m), USD Constant, 2016 49
Table 25: Gynecological Devices Market Pipeline Products 53
Table 26: Hologic Acquires Cynosure in Tender Offer 54
Table 27: Total Number of Primary Research Participants, Diagnostic Imaging Equipment Market, by Country 65

1.2 List of Figures
Figure 1: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 9
Figure 2: Gynecological Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 11
Figure 3: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 13
Figure 4: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 15
Figure 5: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 17
Figure 6: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Historic, 2009-2016 18
Figure 7: Endometrial Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 20
Figure 8: Female Sterilization Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 22
Figure 9: Uterine Fibroid Ablation Devices Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 24
Figure 10: Uterine Fibroid Embolization Agents Market, United States, Revenue ($m), USD Constant, Forecast, 2016-2023 25
Figure 11: Gynecological Devices Market, United States, Volume (Units), Historic, 2009-2016 27
Figure 12: Gynecological Devices Market, United States, Volume (Units), Forecast, 2016-2023 29
Figure 13: Endometrial Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 31
Figure 14: Female Sterilization Devices Market, United States, Volume (Units), Historic, 2009-2016 33
Figure 15: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Historic, 2009-2016 35
Figure 16: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Historic, 2009-2016 36
Figure 17: Endometrial Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 38
Figure 18: Female Sterilization Devices Market, United States, Volume (Units), Forecast, 2016-2023 40
Figure 19: Uterine Fibroid Ablation Devices Market, United States, Volume (Units), Forecast, 2016-2023 42
Figure 20: Uterine Fibroid Embolization Agents Market, United States, Volume (Units), Forecast, 2016-2023 43
Figure 21: Gynecological Devices Market, United States, Company Share (%) 2016 48

$4,995.00

Research Assistance

We can help you find
data and analyses
relevant to your needs,
or prepare a custom report.

Please contact us at [email protected]
or +1 212 564 2838

 

Custom Research

Contact us to speak
with your industry analyst.

[email protected] 
+1 212 564 2838

 



Discount Codes

Request Discount Codes
for reports of interest to you.

[email protected]
+1 212 564 2838



Browse All Reports